跳至主要内容
临床试验/ISRCTN32617901
ISRCTN32617901已完成未知

Effects of supervised physical exercise on cardiotoxicity and cardiac health in women breast cancer survivors during anthracycline-containing chemotherapy: a randomised controlled trial

Centro Hospitalar de Vila Nova de Gaia0 个研究点目标入组 93 人开始时间: 2018年10月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
93

研究概览

简要总结

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31307527 protocol (added 17/07/2019) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36857149/ primary outcome results (added 03/03/2023)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Current inclusion criteria as of 10/01/2019:
  • 2. Aged 18 years or older
  • 3. Histological confirmation of invasive breast cancer
  • 4. Breast cancer stage IA-IIIC
  • 5. Scheduled to receive neoadjuvant or adjuvant anthracycline-containing chemotherapy by decision of the Multidisciplinary Group Consultation of Centro Hospitalar de Vila Nova de Gaia/Espinho
  • 6. Able to provide informed consent
  • 7. Acceptance of randomization to intervention group or control group
  • 8. Baseline assessments before anthracycline-containing chemotherapy begins.
  • Previous inclusion criteria:
  • 2. Aged 18 years or older
  • 3. Histological confirmation of invasive breast cancer
  • 4. Breast cancer stage IA-IIIC
  • 5. Scheduled to receive neoadjuvant or adjuvant anthracycline-containing chemotherapy and/or trastuzumab by the Multidisciplinary Group Consultation of Centro Hospitalar de Vila Nova de Gaia/Espinho decision
  • 6. Able to provide informed consent
  • 7. Acceptance of randomization to intervention group or control group

排除标准

  • Current exclusion criteria as of 10/01/2019:
  • 1. Contraindications to maximal exercise testing
  • 2. Decompensated diabetes mellitus
  • 3. Severe anaemia (<8 g/dl) uncorrectable with transfusion and/or iron and/or vitamin deficiency replacement
  • 4. Significant heart disease (myocardial infarction, congestive heart failure, cardiomyopathy)
  • 5. Usual medication containing beta-blockers
  • 6. Contraindication to exercise
  • Previous exclusion criteria:
  • 1. Heart failure class >1 of the New York Heart Association.
  • 2. Osteoporosis (Tscore < 2.5)
  • 3. Contraindications to maximal exercise testing
  • 4. Usual medication containing beta-blockers
  • 5. Severe anaemia (<8 g/dl) that cannot be corrected with transfusion and/or replacement of iron deficiency and/or vitamin deficiency

研究者

发起方
Centro Hospitalar de Vila Nova de Gaia

相似试验